Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Many healthcare providers and researchers believe that the benefits of semaglutide, such as improved blood sugar control and weight loss, outweigh the potential risks for most patients
The post opens by saying studies show injection technique errors occur in approximately 23% of self-administered GLP-1 cases
A dosing error can have consequences lasting a week or more
Wegovy has you covered across self-pay and commercial channels Novo Nordisk is committed to helping more patients achieve their weight-loss goals with broad access options Self-Pay Savings First two doses of 0.25 mg and 0.5 mg $199 per month* Then $349 per month 1 mg, 1.7 mg, and 2.4 mg doses $349 per month* 7.2 mg dose $399 per month* Commercial Insurance Savings All doses Patients pay as little as With the Wegovy savings offer Tell patients to text SAVE to 83757 , or patients can visit WegovySavings.com to view and sign up for savings offers *Patients new to the Wegovy Savings offer and NovoCare Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg
US$ 20.45
US$ 23.59
US$ 23.26
US$ 26.67
US$ 26.34
US$ 25.08
US$ 28.35
US$ 20.06
US$ 24.85
US$ 24.30
US$ 28.37
